Location History:
- Jarfalla, RU (2009)
- Jarfalla, SE (2013)
Company Filing History:
Years Active: 2009-2013
Title: Innovations of Nikolai Kouznetsov
Introduction
Nikolai Kouznetsov is a notable inventor based in Jarfalla, Sweden. He has made significant contributions to the field of medical research, particularly in therapies related to steroid resistance and edema treatment. With a total of three patents to his name, Kouznetsov's work is paving the way for advancements in therapeutic methods.
Latest Patents
Kouznetsov's latest patents include a method for predicting the response to therapy. This invention involves an in vitro method for selecting therapy for steroid-resistant patients. The process includes isolating cells from a patient sample, cultivating these cells in the presence of steroids or immunomodulatory oligonucleotides, and determining the expression levels of specific marker genes. Examples of these marker genes include CD163, Tsp1, IL1-R2, TLR2, TLR4, MKP-1, and TXK. Another significant patent focuses on compounds for the treatment or alleviation of edema. This patent presents isolated and purified oligonucleotide compounds that effectively reduce swelling and edema, along with novel methods for their application.
Career Highlights
Kouznetsov is currently associated with Index Pharmaceuticals AB, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a strong emphasis on practical applications that can significantly improve patient outcomes.
Collaborations
Kouznetsov collaborates with talented professionals in his field, including Petra Von Stein and Patrik Andersson. Their combined expertise contributes to the advancement of research and development in therapeutic methods.
Conclusion
Nikolai Kouznetsov's contributions to medical research through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of complex medical conditions.